DEBBIE-ANN ANDERSON-DELAINE: Open Payments
NPI 1467851493 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 12 payments from 9 companies in 2025. Trend: 2023 $191 · 2024 $592 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $63 |
| Alkermes, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: Auvelity, LYBALVI, VRAYLAR, HETLIOZ, INGREZZA, TRINTELLIX, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
